Canurta

Transforming Rare Polyphenols into Botanical Drugs

Canurta Therapeutics has brought together leading experts with decades of research experience on polyphenols including flavonoids, cannflavins and stilbenes, to discover novel mechanisms of actions and therapeutic potential with technology-driven drug development.

Our proprietary technology precisely isolates, extracts and standardizes these and other valuable compounds. This enables the creation of both extracts and single molecules that adhere to strict CMC standards.

Optimized by bioinformatics, Canurta's approach streamlines drug development, maximizing innovation, efficiency and therapeutic potential.

Akeem Gardner

Akeem Gardner

  • Chief Executive Officer (CEO)
  • Founder
Sam  Katz

Sam Katz

  • Board of Director
Alex  Chwaiewsky

Alex Chwaiewsky

  • Board of Director
Kyley  Paul

Kyley Paul

  • Board of Director
Ethan  Russo

Ethan Russo

  • Senior Medical Advisor
José  Casaretto

José Casaretto

  • Senior Technical Advisor
Neal  Davies

Neal Davies

  • Principal Investigator, Pharmacokinetics
Tariq  Akhtar

Tariq Akhtar

  • Principal Investigator, Molecule Development
Jasmin  Lalonde

Jasmin Lalonde

  • Principal Investigator, Neuroscience